Characterization of the Giant Foxtail's (

Aristeidis P Papapanagiotou, Maria V Alvanou, Ioannis A Giantsis, Ioannis Vasilakoglou, Ilias G Eleftherohorinos

Abstract read

In one paragraph

Article in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Widespread non-target-site resistance in Setaria viridis to four classes of herbicide.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aristeidis P PapapanagiotouDepartment of Agriculture, University of Western Macedonia, 53100 Florina, Greece.

Maria V AlvanouFaculty of Agriculture, Forestry and Natural Environment, Aristotle University of Thessaloniki, 54621 Thessaloniki, Greece.ORCID 0000-0002-8645-0533

Ioannis A GiantsisFaculty of Agriculture, Forestry and Natural Environment, Aristotle University of Thessaloniki, 54621 Thessaloniki, Greece.ORCID 0000-0002-6323-2955

Ioannis VasilakoglouDepartment of Agriculture-Agrotechnology, University of Thessaly, 41500 Larissa, Greece.ORCID 0000-0003-0393-2981

Ilias G EleftherohorinosDepartment of Field Crops and Ecology, Aristotle University of Thessaloniki, 54621 Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWeed herbicide resistance is a serious problem in crop protection globally. Giant foxtail (

methodsFive putative resistant giant foxtail populations, originating from corn monoculture fields in northeastern Greece, were evaluated for possible evolution of ALS-inhibitor resistance (nicosulfuron, rimsulfuron). The resistance ratio, the underlying resistance mechanism, and its impact on competitive ability against corn were studied.

resultsThe whole-plant rate-response assays showed that these populations were resistant (R) to the sulfonylureas nicosulfuron and rimsulfuron, but susceptible (S) to imidazolinone imazamox, triketone 4-hydroxyphenylpyruvate dioxygenase inhibitor tembotrione, and acetyl-CoA carboxylase inhibitor cycloxydim. The sequencing of the

conclusionsFive giant foxtail populations have evolved metabolism-based resistance to the ALS-inhibiting herbicides nicosulfuron and rimsulfuron.

Indexed as

Acetolactate SynthaseHerbicide ResistancePlant ProteinsPyridinesSetaria PlantSulfonylurea CompoundsHerbicidesZea maysAcetolactate SynthaseHerbicidesnicosulfuronPlant ProteinsPyridinesSulfonylurea CompoundsALS inhibitorscycloxydimgiant foxtailimazamoxnicosulfuronrimsulfuronSetaria faberitembotrioneweed–crop competitionweed resistance

Identifiers

PMID40428327

DOI10.3390/genes16050505

PMCPMC12111008

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.